Clinical Trials Logo

Clinical Trial Summary

Randomized, open-label, 2-period, 2-sequence, crossover study to evaluate the effect of a standard meal on the pharmacokinetic (PK) profile of orally administered RP-G28.


Clinical Trial Description

This randomized, open-label, 2-period, 2-sequence, crossover study is designed to evaluate the effect of a standard meal on the pharmacokinetic (PK) profile of orally administered RP-G28, which is being developed for the treatment of lactose intolerance. The study consists of a screening visit (during the interval from Day -21 to Day -3), baseline/check-in to the clinical research unit (Day -2 to Day -1), 2 treatment periods (Day 1 and Day 3), a 48-hour washout between doses, check-out from the clinical research unit (Day 4), and 1 follow-up phone call conducted 7 to 10 days after the final dose of the study drug (i.e., during the interval from Day 10 to Day 13). The duration of subject study participation is approximately 5 weeks. Plasma samples for PK analysis will be taken at specified timepoints from 24 hours prior to each dose through 24 hours after each dose. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03563846
Study type Interventional
Source Ritter Pharmaceuticals, Inc.
Contact
Status Completed
Phase Phase 1
Start date March 9, 2018
Completion date April 13, 2018

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05100719 - The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION) N/A
Completed NCT02518295 - β-galactosidase Producing Probiotic Strains to Improve Lactose Digestion N/A
Completed NCT00599859 - Effects of Lactose on Fecal Microflora N/A
Completed NCT02636413 - Evaluation of LacTEST for the Diagnosis of Hypolactasia in Adults and Elderly Patients Presenting With Clinical Symptoms of Lactose Intolerance Phase 4
Completed NCT02406469 - Effects Comparison of A1 and A2 Milk on Gastrointestinal Physiology, Symptoms and Cognitive Behavior Phase 4
Terminated NCT00247806 - Prevalence of Lactose Intolerance Following Stem Cell Transplantation Phase 1
Completed NCT03814668 - Effect of Probiotic Supplementation on Lactose Maldigestion Induced by Lactose Solution N/A
Completed NCT03860051 - Association Between Lactase Deficiency, and the Small Intestinal Microbiome in Adults.
Not yet recruiting NCT06107088 - Effect of a Combination of Lactase and L. Salivarius DSM 34078 in Individuals With Lactose Intolerance N/A
Completed NCT02703987 - HYBRID: Hydrogen Breath Test in Lactose Digestion N/A
Completed NCT00395954 - Amount of Lactose Causing Symptoms in Lactose Intolerant People Phase 0
Completed NCT01593800 - The Effect of Probiotics on Lactose Intolerance N/A
Completed NCT04164394 - Effect of I31 Probiotic on Lactose Intolerance N/A
Recruiting NCT05668468 - A Bifido Bacteria to Improve Lactose Digestion and Tolerance N/A
Recruiting NCT02085889 - Fructose and Lactose Intolerance and Malabsorption in Functional Gastrointestinal Disorders
Completed NCT03597516 - Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance Phase 3
Not yet recruiting NCT03563859 - Evaluation of Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance Phase 3
Completed NCT02171403 - Comparison of the Colonic Metabolism in Patients With Lactose Intolerance and Healthy Controls N/A
Completed NCT01145586 - A Non-inferiority, Multicenter and Randomized, Multiple-Dose Study About a Treatment to Hypolactasia Phase 3
Completed NCT02902016 - Modulation of Lactase Expression by a New PPARgamma Ligand in Duodenal Biopsies N/A